Typhon Group PAST TOP 500 CPT CODES OB/GYN/WOMENS HEALTH Page 1 of 2

51845 58353 80074 82107 82043 82106 82105 59000 82143 01968 01961 01960 00840 00848 00851 00790 00846 00948 00952 00940 00944 59425 59426 57240 51840 86850 86631 86694 86696 86701 86703 86689 86762 86787 97032 20610 58322 80048 58953 58956 90911 51700 85027 85025 85014 85018 86900 86904 86901 82272 82270 82274 78350 19102 11100 57100 56605 56606 57500 58340 57511 57513 59320 59514 59515 59620 59622 96413 54160 54150 80502 36591 36416 36415 57452 57455 57454 57456 57460 57461 57420 57421 56820 56821 57260 80418 51726 51741 80053 77051 77052 57520 57522 17340 74160 74150 72193 87076 87070 87075 87040 87071 87086 87088 87110 87102 87101 87081 51570 51550 52000 52005 88104 88175 88174 88142 88143 88147 88141 88164 88166 88150 88152 88154 88153 88162 ABDOMINO-VAGINAL VESICAL NECK SUSPENSION, W/WO ENDOSCOPIC CONTROL ABLATION, ENDOMETRIAL, THERMAL, W/O HYSTEROSCOPIC GUIDANCE ACUTE HEPATITIS PANEL AFP-L3 FRACTION ISOFORM AND TOTAL AFP ALBUMIN; URINE, MICROALBUMIN, QUANTITATIVE ALPHA-FETOPROTEIN; AMNIOTIC FLUID ALPHA-FETOPROTEIN; SERUM AMNIOCENTESIS; DIAGNOSTIC AMNIOTIC FLUID SCAN (SPECTROPHOTOMETRIC) ANESTHESIA FOR CESAREAN DELIVERY FOLLOWING NEURAXIAL LABOR ANALGESIA/ANESTHESIA ANESTHESIA FOR CESAREAN DELIVERY ONLY ANESTHESIA FOR VAGINAL DELIVERY ONLY ANESTHESIA, INTRAPERITONEAL PROC, LOWER ABDOMEN, W/LAPAROSCOPY; NOS ANESTHESIA, INTRAPERITONEAL PROC, LOWER ABDOMEN, W/LAPAROSCOPY; PELVIC EXTENERATION ANESTHESIA, INTRAPERITONEAL PROC, LOWER ABDOMEN, W/LAPAROSCOPY; TUBAL LIGATION/TRANSECTION ANESTHESIA, INTRAPERITONEAL PROC, UPPER ABDOMEN, W/LAPAROSCOPY; NOS ANESTHESIA, INTROPERITONEAL PROC, LOWER ABDOMEN, W/LAPAROSCOPY; RADICAL HYSTERECTOMY ANESTHESIA, VAGINAL PROC, W/BX; CERVICAL CERCLAGE ANESTHESIA, VAGINAL PROC, W/BX; HYSTEROSCOPY &/OR HYSTEROSALPINGOGRAPHY ANESTHESIA, VAGINAL PROC, W/BX; NOS ANESTHESIA, VAGINAL PROC, W/BX; VAGINAL HYSTERECTOMY ANTEPARTUM CARE ONLY; 4 TO 6 VISITS ANTEPARTUM CARE ONLY; 7+ VISITS ANTERIOR COLPORRHAPHY, REPAIR, CYSTOCELE W/WO REPAIR, URETHROCELE ANTERIOR VESICOURETHROPEXY/URETHROPEXY; SIMPLE ANTIBODY SCREEN, RBC, EACH SERUM TECHNIQUE ANTIBODY; CHLAMYDIA ANTIBODY; HERPES SIMPLEX, NON-SPECIFIC TYPE TEST ANTIBODY; HERPES SIMPLEX, TYPE 2 ANTIBODY; HIV-1 ANTIBODY; HIV-1 & HIV-2, SINGLE ASSAY ANTIBODY; HTLV/HIV ANTIBODY, CONFIRMATORY TEST ANTIBODY; RUBELLA ANTIBODY; VARICELLA-ZOSTER APPLICATION, MODALITY TO 1+ AREAS; ELECTRICAL STIMULATION (MANUAL), EACH 15 MIN ARTHROCENTESIS, ASPIRATION &/OR INJECTION; MAJOR JOINT/BURSA ARTIFICIAL INSEMINATION; INTRA-UTERINE BASIC METABOLIC PANEL (CALCIUM, TOTAL) BILAT SALPINGO-OOPHORECT W/OMENTECT, TOTAL ABDOM HYSTER & RADICAL DISSECT DEBULK BILAT SALPINGO-OOPHORECTOMY W/TOTAL OMENTECTOMY/ABDOMINAL HYSTERECTOMY FOR MALIGNANCY BIOFEEDBACK, PERINEAL MUSCLES/ANORECTAL/URETHRAL SPHINCTER, W/EMG TRAINING &/OR MANOMETRY BLADDER IRRIGATION, SIMPLE, LAVAGE &/OR INSTILLATION BLOOD COUNT; COMPLETE CBC, AUTOMATED (HGB, HCT, RBC, WBC, & PLATELET) BLOOD COUNT; COMPLETE CBC, AUTOMATED (HGB, HCT, RBC, WBC, & PLATELET) & AUTOMATED DIFFERENTIAL WBC BLOOD COUNT; HEMATOCRIT BLOOD COUNT; HEMOGLOBIN BLOOD TYPING; ABO BLOOD TYPING; ANTIGEN SCREENING, COMPATIBLE UNIT USING PATIENT SERUM, PER UNIT SCREENED BLOOD TYPING; RH (D) BLOOD, OCCULT, BY PEROXIDASE ACTIVITY QUAL FECES 1-3 SIMUL DETERMINATIONS BLOOD, OCCULT, BY PEROXIDASE ACTIVITY, QUALITATIVE; FECES, CONSEC SPECIMENS BLOOD, OCCULT, FECAL HEMOGLOBIN DETERMIN, IMMUNOASSAY, QUALITATIVE, FECES, 1-3 SIMULTAN DETERMIN BONE DENSITY (BONE MINERAL CONTENT) STUDY, 1+ SITES; SINGLE PHOTON ABSORPTIOMETRY BX, BREAST; PERCUT, NEEDLE CORE, USING IMAGING GUIDANCE BX, SKIN, SUBQ/MUCOUS MEMBRANE; SINGLE LESION BX, VAGINAL MUCOSA; SIMPLE (SEP PROC) BX, VULVA/PERINEUM (SEP PROC); 1 LESION BX, VULVA/PERINEUM (SEP PROC); ADD'L LESION BX/EXCISION, CERVIX LESION W/WO FULGURATION (SEP PROC) CATHETERIZATION & INTRODUCTION, SALINE INFUSION SONOHYSTEROGRAPHY/HYSTEROSALPINGOGRAPHY CAUTERIZATION, CERVIX; CRYOCAUTERY, INITIAL/REPEAT CAUTERIZATION, CERVIX; LASER ABLATION CERCLAGE, CERVIX, DURING PREGNANCY; VAGINAL CESAREAN DELIVERY ONLY CESAREAN DELIVERY ONLY; W/POSTPARTUM CARE CESAREAN DELIVERY, AFTER FAILED VAGINAL DELIVERY, PREVIOUS CESAREAN DELIVERY CESAREAN DELIVERY, AFTER FAILED VAGINAL DELIVERY, PREVIOUS CESAREAN DELIVERY; W/POSTPARTUM CARE CHEMOTHERAPY ADMINISTRATION, IV NFS TQ UP 1 HR 1/1ST SBST/DRUG CIRCUMCISION, SURGICAL EXCISION OTHER THAN CLAMP/DEVICE/DORSAL SLIT; NEONATE (<=28 DAYS OLD) CIRCUMCISION, USING CLAMP/OTHER DEVICE W/REGIONAL DORSAL PENILE OR RING BLOCK CLINICAL PATHOLOGY CONSULTATION; COMPREHENSIVE, W/REVIEW PT HX/RECORDS COLLECTION OF BLOOD SPECIMEN FROM A COMPLETELY IMPLANTABLE VENOUS ACCESS DEVICE COLLECTION, CAPILLARY BLOOD SPECIMEN COLLECTION, VENOUS BLOOD, VENIPUNCTURE COLPOSCOPY, CERVIX W/UPPER ADJACENT VAGINA COLPOSCOPY, CERVIX W/UPPER ADJACENT VAGINA; W/BIOPSY(S), CERVIX COLPOSCOPY, CERVIX W/UPPER ADJACENT VAGINA; W/BIOPSY(S), CERVIX & ENDOCERVICAL CURETTAGE COLPOSCOPY, CERVIX W/UPPER ADJACENT VAGINA; W/ENDOCERVICAL CURETTAGE COLPOSCOPY, CERVIX W/UPPER ADJACENT VAGINA; W/LOOP ELECTRODE BIOPSY(S), CERVIX COLPOSCOPY, CERVIX W/UPPER ADJACENT VAGINA; W/LOOP ELECTRODE CONIZATION, CERVIX COLPOSCOPY, ENTIRE VAGINA, W/CERVIX IF PRESENT COLPOSCOPY, ENTIRE VAGINA, W/CERVIX IF PRESENT; W/BIOPSY(S) VAGINA/CERVIX COLPOSCOPY, VULVA COLPOSCOPY, VULVA; W/BIOPSY(S) COMBINED ANTEROPOSTERIOR COLPORRHAPHY COMBINED RAPID ANTERIOR PITUITARY EVAL PANEL COMPLEX CYSTOMETROGRAM COMPLEX UROFLOWMETRY COMPREHENSIVE METABOLIC PANEL COMPUTER-AIDED DETECTION DX MAMMOGRAPHY COMPUTER-AIDED DETECTION SCREENING MAMMOGRAPHY CONIZATION, CERVIX W/WO FULGURATION, W/WO D&C/REPAIR; COLD KNIFE/LASER CONIZATION, CERVIX W/WO FULGURATION, W/WO D&C/REPAIR; LOOP CRYOTHERAPY (CO2 SLUSH, LIQUID N2) FOR ACNE CT SCAN, ABDOMEN; W/CONTRAST MATL(S) CT SCAN, ABDOMEN; W/O CONTRAST MATL CT SCAN, PELVIS; W/CONTRAST MATL(S) CULTURE, BACTERIAL; ANAEROBIC ISOLATE, ADD'L METHODS REQUIRED FOR DEFINITIVE ID, EA ISOLATE CULTURE, BACTERIAL; ANY OTHER SOURCE EXCEPT URINE/BLOOD/STOOL, AEROBIC, W/ISOLATN/PRESUMPTIVE ID CULTURE, BACTERIAL; ANY SOURCE, EXCEPT BLOOD, ANAEROBIC W/ISOLATN/PRESUMPTIVE ID, ISOLATES CULTURE, BACTERIAL; BLOOD, AEROBIC, W/ ISOLATN/PRESUMPTIVE ID, ISOLATES (W/ ANAEROBIC CULTURE) CULTURE, BACTERIAL; QUANTIT, AEROBIC W/ISOLATN & ID ISOLATES, ANY SOURCE EXCEPT URINE/BLOOD/STOOL CULTURE, BACTERIAL; QUANTITATIVE COLONY COUNT, URINE CULTURE, BACTERIAL; W/ISOLATION & PRESUMPTIVE ID OF EACH ISOLATE, URINE CULTURE, CHLAMYDIA, ANY SOURCE CULTURE, FUNGI (MOLD/YEAST) ISOLATION, W/PRESUMPTIVE ID OF ISOLATES; OTHER SOURCE, EXCEPT BLOOD CULTURE, FUNGI (MOLD/YEAST) ISOLATION, W/PRESUMPTIVE ID OF ISOLATES; SKIN/HAIR/NAIL CULTURE, PRESUMPTIVE, PATHOGENIC ORGANISMS, SCREENING ONLY CYSTECTOMY, COMPLETE; (SEP PROC) CYSTECTOMY, PARTIAL; SIMPLE CYSTOURETHROSCOPY (SEP PROC) CYSTOURETHROSCOPY, W/URETERAL CATHETERIZATION CYTOPATHOLOGY EXCEPT CERVICAL/VAGINAL; SMEARS W/INTERPRETATION CYTOPATHOLOGY, CERVICAL/VAGINAL, AUTO THIN LAYER PREP; AUTO SCREEN & MANUAL RESCREEN, W/PHYS CYTOPATHOLOGY, CERVICAL/VAGINAL, AUTO THIN LAYER PREP; AUTO SCREEN, W/PHYS INTERP CYTOPATHOLOGY, CERVICAL/VAGINAL, PRESERVATIVE FLUID, AUTO THIN LAYER PREP; MANUAL SCREEN CYTOPATHOLOGY, CERVICAL/VAGINAL, PRESERVATIVE FLUID, AUTO THIN LAYER PREP; MANUAL SCREEN/RESCREEN CYTOPATHOLOGY, CERVICAL/VAGINAL; AUTOMATED SCREEN CYTOPATHOLOGY, CERVICAL/VAGINAL; REQUIRING INTERPRETATION, PHYSICIAN CYTOPATHOLOGY, SLIDES, CERVICAL/VAGINAL, BETHESDA; MANUAL SCREEN CYTOPATHOLOGY, SLIDES, CERVICAL/VAGINAL, BETHESDA; W/MANUAL SCREEN & COMPUTER RESCREEN CYTOPATHOLOGY, SLIDES, CERVICAL/VAGINAL; MANUAL SCREEN CYTOPATHOLOGY, SLIDES, CERVICAL/VAGINAL; MANUAL SCREEN, COMPUTER RESCREEN CYTOPATHOLOGY, SLIDES, CERVICAL/VAGINAL; MANUAL SCREEN, COMPUTER RESCREEN, CELL SELECTION CYTOPATHOLOGY, SLIDES, CERVICAL/VAGINAL; MANUAL SCREEN/RESCREEN CYTOPATHOLOGY, SMEARS, OTHER SOURCE; EXTENDED STUDY, > 5 SLIDES &/OR MULTIPLE STAINS 88160 87166 87164 82627 59414 94664 17110 17111 56515 56501 17000 57061 57170 57558 58120 57800 76820 58805 16030 16025 80100 76825 76828 76827 76856 76857 76830 93000 51784 99284 99281 99285 99282 99283 57505 58110 58100 58356 87320 87340 87390 59300 82670 82677 82672 56740 57555 57135 49000 59412 76818 76819 59020 82731 59051 59050 59025 57160 80050 82962 82948 82950 82947 82953 82951 82952 84704 84703 84702 83001 83002 99000 83020 83036 83037 83051 80076 86704 86706 86803 99506 99501 99500 99239 99238 90649 90650 83498 74740 58555 58565 58563 58558 58559 58561 90471 90472 86304 11980 10061 10060 56420 10180 56405 59840 59841 59855 87270 87850 87880 87802 87801 87800 87797 87480 87485 87491 87490 87510 87528 87621 87620 87622 87591 87590 87650 CYTOPATHOLOGY, SMEARS, OTHER SOURCE; SCREENING & INTERPRETATION DARK FIELD EXAM, ANY SOURCE; W/O COLLECTION DARK FIELD EXAM, ANY SOURCE; W/SPECIMEN COLLECTION DEHYDROEPIANDROSTERONE-SULFATE (DHEA-S) DELIVERY, PLACENTA (SEP PROC) DEMONSTRATE &/OR EVAL, PT USE, AEROSOL GENERATOR/NEBULIZER/INHALER/IPPB DEVICE DESTRUCTION, BENIGN LESIONS, EXCEPT SKIN TAGS/CUTANEOUS VASC LESIONS; UP TO 14 LESIONS DESTRUCTION, FLAT WARTS, MOLLUSCUM CONTAGIOSUM/MILIA; 15 + DESTRUCTION, LESION(S), VULVA; EXTENSIVE DESTRUCTION, LESION(S), VULVA; SIMPLE DESTRUCTION, PREMALIG LESIONS; 1ST LESION DESTRUCTION, VAGINAL LESION(S); SIMPLE DIAPHRAGM/CERVICAL CAP FITTING W/INSTRUCTIONS DILATION & CURETTAGE CERVICAL STUMP DILATION & CURETTAGE, DX &/OR THERAPEUTIC (NONOBSTETRICAL) DILATION, CERVICAL CANAL, INSTRUMENTAL (SEP PROC) DOPPLER VELOCIMETRY, FETAL; UMBILICAL ARTERY DRAINAGE, OVARIAN CYST(S), UNILAT/BILAT, (SEP PROC); ABDOMINAL APPROACH DRESSINGS &/OR DEBRIDEMENT, INITIAL/SUBSEQUENT; LARGE DRESSINGS &/OR DEBRIDEMENT, INITIAL/SUBSEQUENT; MEDIUM DRUG SCREEN, QUALITATIVE; MULTIPLE DRUG CLASSES CHROMATOGRAPHIC METHOD, EACH PROC ECHOCARDIOGRAPHY, FETAL, CARDIOVASCULAR SYSTEM, REAL TIME W/WO M-MODE ECHOCARDIOGRAPHY, FETAL, DOPPLER, CARDIOVASCULAR SYSTEM; FOLLOW-UP/REPEAT ECHOCARDIOGRAPHY, FETAL, DOPPLER; COMPLETE ECHOGRAPHY, PELVIC (NONOBSTETRIC), REAL TIME W/IMAGE DOCUMENTATION; COMPLETE ECHOGRAPHY, PELVIS, B-SCAN/REAL TIME; LIMITED/FOLLOW-UP ECHOGRAPHY, TRANSVAGINAL ELECTROCARDIOGRAM, ROUTINE W/AT LEAST 12 LEADS; W/INTERPRETATION & REPORT ELECTROMYOGRAPHY STUDIES, ANAL/URETHRAL SPHINCTER, OTHER THAN NEEDLE, ANY TECHNIQUE EMERGENCY DEPT VISIT, 3 KEY COMPONENTS: DETAILED HX; DETAILED EXAM; MED DECISION MOD COMPLEXITY EMERGENCY DEPT VISIT, 3 KEY COMPONENTS: PROB FOCUS HX; PROB FOCUS EXAM; STRTFWD MED DECISION EMERGENCY DEPT VISIT, 3 KEY COMPONENTS:COMPREHENSIVE HX; COMPREHENSIVE EXAM; MED DECISN HIGH EMERGENCY DEPT VISIT,3 KEY COMPONENTS:EXPAND PROB FOCUS HX;EXPAND PROB FOCUS EXAM;MED DEC LOW EMERGENCY DEPT VISIT,3 KEY COMPONENTS:EXPAND PROB FOCUS HX;EXPAND PROB FOCUS EXAM;MED DEC MOD ENDOCERVICAL CURETTAGE (NOT DONE AS PART OF A DILATION & CURETTAGE) ENDOMETRIAL BX CONJUNCTION W/COLPOSCOPY ENDOMETRIAL BX W/WO ENDOCERVICAL BX, W/O DILATION, ANY METHOD (SEP PROC) ENDOMETRIAL CRYOABLATION W/US, W/ENDOMETRIAL CURETTAGE, WHEN PERFORMED ENZYME IMMUNOASSAY (EIA), QUALITATIVE/SEMIQUANTITATIVE, MULTIPLE STEP; CHLAMYDIA TRACHOMATIS ENZYME IMMUNOASSAY (EIA), QUALITATIVE/SEMIQUANTITATIVE, MULTIPLE STEP; HEPATITIS B SURFACE ANTIGEN ENZYME IMMUNOASSAY (EIA), QUALITATIVE/SEMIQUANTITATIVE, MULTIPLE STEP; HIV-1 EPISIOTOMY/VAGINAL REPAIR, OTHER THAN ATTENDING PHYSICIAN ESTRADIOL ESTRIOL ESTROGENS; TOTAL EXCISION, BARTHOLIN'S GLAND/CYST EXCISION, CERVICAL STUMP, VAGINAL APPROACH; W/ANTERIOR &/OR POSTERIOR REPAIR EXCISION, VAGINAL CYST/TUMOR EXPLORATORY LAPAROTOMY, EXPLORATORY CELIOTOMY W/WO BX(S) (SEP PROC) EXT CEPHALIC VERSION, W/WO TOCOLYSIS FETAL BIOPHYSICAL PROFILE; W/NON-STRESS TESTING FETAL BIOPHYSICAL PROFILE; W/O NON-STRESS TESTING FETAL CONTRACTION STRESS TEST FETAL FIBRONECTIN, CERVICOVAGINAL SECRETIONS, SEMI-QUANTITATIVE FETAL MONITORING IN LABOR, PHYSICIAN W/WRITTEN REPORT; INTREPRETATION ONLY FETAL MONITORING IN LABOR, PHYSICIAN W/WRITTEN REPORT; S & I FETAL NON-STRESS TEST FITTING & INSERTION, PESSARY/OTHER INTRAVAGINAL SUPPORT DEVICE GENERAL HEALTH PANEL GLUCOSE, BLOOD, GLUCOSE MONITORING DEVICE(S) CLEARED BY FDA SPECIFICALLY FOR HOME USE GLUCOSE; BLOOD, REAGENT STRIP GLUCOSE; POST GLUCOSE DOSE (INCLUDES GLUCOSE) GLUCOSE; QUANTITATIVE, BLOOD (EXCEPT REAGENT STRIP) GLUCOSE; TOLBUTAMIDE TOLERANCE TEST GLUCOSE; TOLERANCE TEST (GTT), 3 SPECIMENS (INCLUDES GLUCOSE) GLUCOSE; TOLERANCE TEST, EACH ADD'L BEYOND 3 SPECIMENS GONADOTROPIN, CHORIONIC (HCG); FREE BETA CHAIN GONADOTROPIN, CHORIONIC (HCG); QUALITATIVE GONADOTROPIN, CHORIONIC (HCG); QUANTITATIVE GONADOTROPIN; FOLLICLE STIMULATING HORMONE (FSH) GONADOTROPIN; LUTEINIZING HORMONE (LH) HANDLING &/OR CONVEYANCE, SPECIMEN TRANSFER, PHYSICIAN'S OFFICE TO LAB HEMOGLOBIN FRACTIONATION & QUANTITATION; ELECTROPHORESIS HEMOGLOBIN; GLYCOSYLATED (A1C) HEMOGLOBIN; GLYCOSYLATED (A1C) BY DEVICE CLEARED BY FDA FOR HOME USE HEMOGLOBIN; PLASMA HEPATIC FUNCTION PANEL HEPATITIS B CORE ANTIBODY (HBCAB); TOTAL HEPATITIS B SURFACE ANTIBODY (HBSAB) HEPATITIS C ANTIBODY HOME VISIT, IM INJECTIONS HOME VISIT, POSTNATAL ASSESSMENT, FOLLOW-UP CARE HOME VISIT, PRENAT MONITOR ASSESS, FETAL HEART RATE, NON-STRESS TEST, UTERINE, GESTAT DIABET MONITOR HOSPITAL DISCHARGE DAY MANAGEMENT; > 30 MIN HOSPITAL DISCHARGE DAY MANAGEMENT; UP TO 30 MIN HPV TYP 6 11 16 18 QUADRIV 3 DOSE SCHED IM HPV VACCINE BIVALENT 3 DOSE IM HYDROXYPROGESTERONE, 17-D HYSTEROSALPINGOGRAPHY, RADIOLOGICAL S&I HYSTEROSCOPY, DX (SEP PROC) HYSTEROSCOPY, SURGICAL; W/BILAT FALLOPIAN CANNULATION FOR OCCLUSION/PERMANENT IMPLANT PLACEMNT HYSTEROSCOPY, SURGICAL; W/ENDOMETRIAL ABLATION HYSTEROSCOPY, SURGICAL; W/ENDOMETRIAL BX &/OR POLYPECTOMY W/WO D&C HYSTEROSCOPY, SURGICAL; W/LYSIS INTRAUTERINE ADHESIONS, ANY METHOD HYSTEROSCOPY, SURGICAL; W/REMOVAL LEIOMYOMATA IMMUNIZATION ADMINISTRATION; 1 SINGLE/COMBINATION VACCINE/TOXOID IMMUNIZATION ADMINISTRATION; EACH ADD'L SINGLE/COMBINATION VACCINE/TOXOID IMMUNOASSAY, TUMOR ANTIGEN, QUANTITATIVE; CA 125 IMPLANTATION, HORMONE PELLET, SUBCUTANEOUS INCISION & DRAINAGE, ABSCESS; COMPLICATED/MULTIPLE INCISION & DRAINAGE, ABSCESS; SIMPLE/SINGLE INCISION & DRAINAGE, BARTHOLIN'S GLAND ABSCESS INCISION & DRAINAGE, COMPLEX, POSTOPERATIVE WOUND INFECTION INCISION & DRAINAGE, VULVA/PERINEAL ABSCESS INDUCED ABORTION, DILATION & CURETTAGE INDUCED ABORTION, DILATION & EVACUATION INDUCED ABORTION, VAGINAL SUPPOSITORIES W/HOSPITAL ADMISSION/VISITS/DELIVERY INFECTIOUS AGENT ANTIGEN DETECTION BY IMMUNOFLUORESCENT TECHNIQUE; CHLAMYDIA TRACHOMATIS INFECTIOUS AGENT, IMMUNOASSAY, DIRECT OBSERVATION; NEISSERIA GONORRHOEAE INFECTIOUS AGENT, IMMUNOASSAY, DIRECT OBSERVATION; STREPOCOCCUS GROUP A INFECTIOUS AGENT, IMMUNOASSAY, DIRECT OBSERVATION; STREPTOCOCCUS GROUP B INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA), MULTIPLE ORGANISMS; AMPLIFIED PROBE(S) TECHNIQUE INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA), MULTIPLE ORGANISMS; DIRECT PROBE(S) TECHNIQUE INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA), NOS; DIRECT PROBE TECHNIQUE, EA ORGANISM INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); CANDIDA, DIRECT PROBE INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); CHLAMYDIA PNEUMONIAE, DIRECT PROBE INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); CHLAMYDIA TRACHOMATIS, AMPLIFIED PROBE INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); CHLAMYDIA TRACHOMATIS, DIRECT PROBE INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); GARDNERELLA VAGINALIS, DIRECT PROBE INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); HERPES SIMPLEX VIRUS, DIRECT PROBE INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); HUMAN PAPILLOMAVIRUS, AMPLIFIED PROBE INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); HUMAN PAPILLOMAVIRUS, DIRECT PROBE INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); HUMAN PAPILLOMAVIRUS, QUANTIFICATION INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); NEISSERIA GONORRHOEAE, AMPLIFIED PROBE INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); NEISSERIA GONORRHOEAE, DIRECT PROBE INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); STREPTOCOCCUS GROUP A, DIRECT PROBE

CPT is a registered trademark of the American Medical Association

Typhon Group PAST TOP 500 CPT CODES OB/GYN/WOMENS HEALTH Page 2 of 2
87653 87660 90663 90658 90656 90655 86336 99384 99385 99386 99383 99387 99381 99223 99222 99221 99460 99463 99220 99219 99218 64435 64483 62282 99253 99251 99254 99255 99252 59200 11975 58300 11981 51701 51702 90887 77777 36000 31500 83540 57150 96361 96360 96365 59151 58543 58544 58541 58542 49320 58545 58553 58554 58550 58552 58570 58571 58573 51992 49321 49322 58670 58662 58660 58671 58661 58960 88305 58611 58605 58600 83690 80061 58740 83735 77056 77055 56440 19301 19302 51798 96040 99606 57267 83890 58145 58140 58146 01967 94760 99217 80055 99236 99235 99234 58615 99245 99243 99241 99244 99242 99058 99214 99213 99212 99215 99211 99203 99202 99201 99205 99204 58940 58925 57285 57284 99071 57410 99394 99392 99395 99396 99393 99397 99391 83986 INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); STREPTOCOCCUS GROUP B AMPLIFIED PROBE TQ INFECTIOUS AGENT, NUCLEIC ACID (DNA/RNA); TRICHOMONAS VAGINALIS, DIRECT PROBE INFLUENZA VIRUS VACCINE, PANDEMIC FORMULATION, H1N1 INFLUENZA VIRUS VACCINE, SPLIT, 3 YEARS +, IM USE INFLUENZA VIRUS VACCINE, SPLIT, PRESERVATIVE FREE, 3+YRS, IM USE INFLUENZA VIRUS VACCINE, SPLIT, PRESERVATIVE FREE, 6-35 MONTHS, IM USE INHIBIN A INITIAL COMPREHENSIVE PREVENTIVE MEDICINE E&M W/HX/EXAM, NEW PT; 12-17 YR INITIAL COMPREHENSIVE PREVENTIVE MEDICINE E&M W/HX/EXAM, NEW PT; 18-39 YR INITIAL COMPREHENSIVE PREVENTIVE MEDICINE E&M W/HX/EXAM, NEW PT; 40-64 YR INITIAL COMPREHENSIVE PREVENTIVE MEDICINE E&M W/HX/EXAM, NEW PT; 5-11 YR INITIAL COMPREHENSIVE PREVENTIVE MEDICINE E&M W/HX/EXAM, NEW PT; 65+ YR INITIAL COMPREHENSIVE PREVENTIVE MEDICINE E&M W/HX/EXAM, NEW PT; INFANT < 1 YR INITIAL HOSP CARE 3 KEY COMPONENTS: COMPREHENSIVE HX; COMPREHENSIVE EXAM; MED DECISION HIGH INITIAL HOSP CARE 3 KEY COMPONENTS: COMPREHENSIVE HX; COMPREHENSIVE EXAM; MED DECISION MOD INITIAL HOSP CARE 3 KEY COMPONENTS:DETAIL/COMPREHENSV HX;DETAIL/COMPREHENSV EXAM;MED DEC STRTF INITIAL HOSP/BIRTHING CENTER CARE PER DAY NORMAL NEWBORN INITIAL HOSP/BIRTHING CENTER NEWBORN ADMIT&DSCHG SM DATE INITIAL OBSV CARE, 3 KEY COMPONENTS: COMPREHENSIVE HX; COMPREHENSIVE EXAM; MED DECISION HIGH INITIAL OBSV CARE, 3 KEY COMPONENTS: COMPREHENSIVE HX;COMPREHENSIVE EXAM;MED DECISION MOD INITL OBSV CARE, 3 KEY COMPONENTS: DETAIL/COMPREHENSV HX;DETAIL/COMPREHENSV EXAM;MED DEC STRTF INJECTION, ANESTHETIC AGENT; PARACERVICAL (UTERINE) NERVE INJECTION, ANESTHETIC/STEROID, TRANSFORAMINAL EPIDURAL; LUMBAR/SACRAL, SINGLE LEVEL INJECTION/INFUSION NEUROLYTIC SUBSTANCE, W/WO THERAPEUTIC SUBSTANCE; EPIDURAL, LUMBAR/CAUDAL INPATIENT CONSULT, 3 KEY COMPONENTS: DETAILED HX; DETAILED EXAM; MED DECISION LOW COMPLEX INPATIENT CONSULT, 3 KEY COMPONENTS: PROB FOCUS HX; PROB FOCUS EXAM; STRTFWD MED DECISION INPATIENT CONSULT, 3 KEY COMPONENTS:COMPREHENSIVE HX;COMPREHENSIVE EXAM; MED DECISION MOD INPATIENT CONSULT, 3 KEY COMPONENTS:COMPREHENSIVE HX;COMPREHENSIVE EXAM;MED DECISION HIGH INPATIENT CONSULT, 3 KEY COMPONENTS:EXPAND PROB FOCUS HX;EXPAND PROB FOCUS EXAM;STRTFWD MED INSERTION, CERVICAL DILATOR (SEP PROC) INSERTION, IMPLANTABLE CONTRACEPTIVE CAPSULES INSERTION, INTRAUTERINE DEVICE INSERTION, NON-BIODEGRADABLE DRUG DELIVERY IMPLANT INSERTION, NON-INDWELLING BLADDER CATHETER INSERTION, TEMPORARY INDWELLING BLADDER CATHETER; SIMPLE INTERPRETATION/EXPLANATION RESULTS, PSYCHIATRIC/MEDICAL EXAM/PROC W/FAMILY INTERSTITIAL RADIOELEMENT APPLICATION; INTERMEDIATE INTRODUCTION, NEEDLE/INTRACATHETER, VEIN INTUBATION, ENDOTRACHEAL, EMERGENCY PROC IRON IRRIGATION/TREATMENT, VAGINAL INFECTION IV INFUSION HYDRATION EACH ADDITIONAL HOUR IV INFUSION HYDRATION INITIAL 31 MIN-1 HOUR IV INFUSION THERAPY/PROPHYLAXIS /DX 1ST >1 HOUR LAPAROSCOPIC TREATMENT, ECTOPIC PREGNANCY; W/SALPINGECTOMY &/OR OOPHORECTOMY LAPAROSCOPY SUPRACERVICAL HYSTERECTOMY >250 G LAPAROSCOPY SUPRACERVICAL HYSTERECTOMY >250 G RMVL TUBE/OVARY LAPAROSCOPY SUPRACERVICAL HYSTERECTOMY 250 G/< LAPAROSCOPY SUPRACERVICAL HYSTERECTOMY 250 G/< RMVL TUBE/OVARY LAPAROSCOPY, ABDOMEN, PERITONEUM & OMENTUM, DX, W/WO SPECIMEN(S), BRUSHING/WASHING (SEP PROC) LAPAROSCOPY, SURG, MYOMECTOMY; 1-4 INTRAMURAL MYOMAS, TOTAL WT 250 GMS,REMOVE SURFACE MYOMAS LAPAROSCOPY, SURG, W/VAGINAL HYSTERECTOMY, UTERUS >250GMS LAPAROSCOPY, SURG, W/VAGINAL HYSTERECTOMY, UTERUS >250GMS; W/REMOVE TUBE(S) &/OR OVARY(S) LAPAROSCOPY, SURG, W/VAGINAL HYSTERECTOMY, UTERUS 250GMS/< LAPAROSCOPY, SURG, W/VAGINAL HYSTERECTOMY, UTERUS 250GMS/<; W/REMOVAL, TUBE(S) &/OR OVARY(S) LAPAROSCOPY, SURGICAL, TOTAL HYSTERECTOMY, UTERUS 250 G OR LESS; LAPAROSCOPY, SURGICAL, TOTAL HYSTERECTOMY, UTERUS 250 G OR LESS; WITH REMOVAL OF TUBES,OVARYS LAPAROSCOPY, SURGICAL, TOTAL HYSTERECTOMY, UTERUS GREATER THAN 250 G; REMOVAL OF TUBES,OVARYS LAPAROSCOPY, SURGICAL; SLING OPERATION FOR STRESS INCONTINENCE LAPAROSCOPY, SURGICAL; W/BX (SINGLE/MULTIPLE) LAPAROSCOPY, SURGICAL; W/CAVITY/CYST ASPIRATION LAPAROSCOPY, SURGICAL; W/FULGURATION OF OVIDUCTS W/WO TRANSECTION LAPAROSCOPY, SURGICAL; W/FULGURATION/EXCISION, LESIONS OF OVARY/PELVIC VISCERA/PERITONEAL SURFACE LAPAROSCOPY, SURGICAL; W/LYSIS, ADHESIONS (SALPINGOLYSIS/OVARIOLYSIS) (SEP PROC) LAPAROSCOPY, SURGICAL; W/OCCLUSION, OVIDUCTS BY DEVICE LAPAROSCOPY, SURGICAL; W/REMOVAL, ADNEXAL STRUCTURES LAPAROTOMY, STAGING/RESTAGING, OVARIAN/TUBAL/PRIMARY MALIGNANCY (\2ND LOOK\) LEVEL IV - SURGICAL PATHOLOGY, GROSS & MICROSCOPIC EXAM LIGATION/TRANSECTION, FALLOPIAN TUBE W/C-SECTION/SURGERY LIGATION/TRANSECTION, FALLOPIAN TUBE, ABD/VAGINAL APPROACH, POSTPARTUM (SEP PROC) LIGATION/TRANSECTION, FALLOPIAN TUBE, ABD/VAGINAL APPROACH, UNILAT/BILAT LIPASE LIPID PANEL LYSIS, ADHESIONS (SALPINGOLYSIS, OVARIOLYSIS) MAGNESIUM MAMMOGRAPHY BILATERAL MAMMOGRAPHY UNILATERAL MARSUPIALIZATION, BARTHOLIN'S GLAND CYST MASTECTOMY PARTIAL MASTECTOMY PARTIAL W/AX LMPHADEC MEASUREMENT, POST-VOIDING RESIDUAL URINE &/OR BLADDER CAPACITY, US, NON-IMAGING MEDICAL GENETICS COUNSELING EA 30 MIN MEDICATION THERAPY F2F 1ST 15 MIN ESTABLISHED PT MESH/PROSTHESIS INSERTION, FOR PELVIC FLOOR DEFECT REPAIR, EA SITE, VAGINAL APPROACH MOLECULAR DX; MOLECULAR ISOLATION/EXTRACTION, EACH NUCLEIC ACID TYPE MYOMECTOMY 1-4 MYOMA(S), W/TOTAL WEIGHT 250 GMS/<; VAGINAL APPROACH MYOMECTOMY 1-4 MYOMA(S), W/TOTAL WEIGHT 250GMS/<; ABDOMINAL APPROACH MYOMECTOMY 5/> INTRAMURAL MYOMAS &/OR TOTAL WT >250 GMS, ABDOMINAL APPROACH NEURAXIAL LABOR ANALGESIA/ANESTHESIA, PLANNED VAGINAL DELIVERY NONINVASIVE EAR/PULSE OXIMETRY, OXYGEN SATURATION; SINGLE DETERMINATION OBSERVATION CARE DISCHARGE DAY MGT OBSTETRIC PANEL OBSV/INPT HOSP CARE 3 KEY COMPONENTS: COMPREHENSIVE HX; COMPREHENSIVE EXAM; MED DECISION HIGH OBSV/INPT HOSP CARE 3 KEY COMPONENTS: COMPREHENSIVE HX; COMPREHENSIVE EXAM; MED DECISION MOD OBSV/INPT HOSP CARE 3 KEY COMPONENTS: DETAIL/COMPR HX; DETAIL/COMPR EXAM;MED DEC STRTFWD/LOW OCCLUSION, FALLOPIAN TUBE BY DEVICE, VAGINAL/SUPRAPUBIC APPROACH OFFICE CONSULTATION, 3 KEY COMPONENTS: COMPREHENSIVE HX;COMPREHENSIVE EXAM;MED DECISION HIGH OFFICE CONSULTATION, 3 KEY COMPONENTS: DETAILED HX; DETAILED EXAM; MED DECISION LOW COMPLEXITY OFFICE CONSULTATION, 3 KEY COMPONENTS: PROB FOCUS HX; PROB FOCUS EXAM; STRTFWD MED DECISION OFFICE CONSULTATION, 3 KEY COMPONENTS:COMPREHENSIVE HX; COMPREHENSIVE EXAM; MED DECISION MOD OFFICE CONSULTATION, 3 KEY COMPONENTS:EXPAND PROB FOCUS HX;EXPAND PROB FOCUS EXAM;STRTFWD MED OFFICE SERVICES, EMERGENCY BASIS DISRUPTS OFFICE SVC OFFICE/OP VISIT, EST PT, 2 KEY COMPONENTS: DETAILED HX; DETAILED EXAM; MED DECISION MOD COMPLEXITY OFFICE/OP VISIT, EST PT, 2 KEY COMPONENTS: EXPAND PROB HX; EXPAND PROB EXAM;MED DECISION LOW OFFICE/OP VISIT, EST PT, 2 KEY COMPONENTS: PROB FOCUS HX; PROB FOCUS EXAM; STRTFWD MED DECISION OFFICE/OP VISIT, EST PT, 2 KEY COMPONENTS:COMPREHENSIVE HX;COMPREHENSIV EXAM;MED DECISN HIGH OFFICE/OP VISIT, EST PT, NOT REQUIRING PHYSICIAN PRESENCE, TYPICALLY 5 MIN OFFICE/OP VISIT, NEW PT, 3 KEY COMPONENTS: DETAILED HX; DETAILED EXAM; MED DECISION LOW COMPLEXITY OFFICE/OP VISIT, NEW PT, 3 KEY COMPONENTS: EXPAND PROB FOCUS HX; EXPAND PROB FOCUS EXAM; STRTFWD OFFICE/OP VISIT, NEW PT, 3 KEY COMPONENTS: PROB FOCUS HX; PROB FOCUS EXAM; STRTFRWD MED DECISION OFFICE/OP VISIT, NEW PT, 3 KEY COMPONENTS:COMPREHENSIVE HX;COMPREHENSIV EXAM;MED DECISN HIGH OFFICE/OP VISIT, NEW PT, 3 KEY COMPONENTS:COMPREHENSIVE HX;COMPREHENSIVE EXAM;MED DECISN MOD OOPHORECTOMY, PARTIAL/TOTAL, UNILAT/BILAT OVARIAN CYSTECTOMY, UNILAT/BILAT PARAVAGINAL DEFECT REPAIR (INCLUDING REPAIR OF CYSTOCELE, IF PERFORMED); VAGINAL APPROACH PARAVAGINAL DEFECT REPAIR (W/REPAIR, CYSTOCELE) PATIENT EDUCATION MATLS PROVIDED BY PHYSICIAN PELVIC EXAM UNDER ANESTHESIA PERIODIC COMPREHENSIVE PREVENTIVE MEDICINE E&M W/HX/EXAM, EST PT; 12-17 YR PERIODIC COMPREHENSIVE PREVENTIVE MEDICINE E&M W/HX/EXAM, EST PT; 1-4 YR PERIODIC COMPREHENSIVE PREVENTIVE MEDICINE E&M W/HX/EXAM, EST PT; 18-39 YR PERIODIC COMPREHENSIVE PREVENTIVE MEDICINE E&M W/HX/EXAM, EST PT; 40-64 YR PERIODIC COMPREHENSIVE PREVENTIVE MEDICINE E&M W/HX/EXAM, EST PT; 5-11 YR PERIODIC COMPREHENSIVE PREVENTIVE MEDICINE E&M W/HX/EXAM, EST PT; 65+ YR PERIODIC COMPREHENSIVE PREVENTIVE MEDICINE E&M W/HX/EXAM, EST PT; INFANT < 1 YR PH, BODY FLUID, NOS 97750 57250 99024 59430 94640 99401 99402 84144 84146 99356 99355 84156 85610 19000 92552 71020 69210 59871 65205 11976 58301 11200 15851 57268 45560 90384 59618 59510 59400 59610 76831 58700 58720 77057 85660 51725 51736 86580 57288 87205 87210 99233 99232 99231 99462 99224 99070 58180 59120 87181 86592 86593 84402 84403 90715 96372 85730 84479 84443 84439 87220 99406 58150 58152 58200 36430 59812 59820 12021 84481 76813 76705 76700 76645 76770 88199 99499 19499 58999 58579 58679 58578 59899 76999 84550 81001 81003 81000 81002 81007 81015 81005 81025 76977 76946 76970 76812 76811 76810 76802 76801 76805 76816 76815 76817 59409 59410 59612 59614 58290 58291 58260 58262 58263 58270 58275 58280 90716 36410 82306 51797 56620 PHYSICAL PERFORMANCE TEST, W/WRITTEN REPORT, EACH 15 MIN POSTERIOR COLPORRHAPHY, REPAIR, RECTOCELE W/WO PERINEORRHAPHY POSTOPERATIVE FOLLOW-UP VISIT, INCLUDED SURGICAL PACKAGE, E/M PERFORMED POSTPARTUM CARE ONLY (SEP PROC) PRESSURIZED/NONPRESSURIZED INHALATION RX, AIRWAY OBSTRUCTION/DX SPUTUM INDUCTION PREVENTIVE MEDICINE COUNSELING, INDIV; 15 MIN PREVENTIVE MEDICINE COUNSELING, INDIV; 30 MIN PROGESTERONE PROLACTIN PROLONGED PHYSICIAN SERVICE, INPT W/DIRECT CONTACT; 1ST HR PROLONGED PHYSICIAN SERVICE, OFFICE/OP W/DIRECT CONTACT; ADD'L 30 MIN PROTEIN, TOTAL, EXCEPT REFRACTOMETRY; URINE PROTHROMBIN TIME PUNCTURE ASPIRATION, CYST, BREAST; PURE TONE AUDIOMETRY (THRESHOLD); AIR ONLY RADIOLOGIC EXAM, CHEST, 2 VIEWS, FRONTAL & LATERAL REMOVAL IMPACTED CERUMEN (SEP PROC), ONE/BOTH EARS REMOVAL, CERCLAGE SUTURE UNDER ANESTHESIA (OTHER THAN LOCAL) REMOVAL, FB, EXT EYE; CONJUNCTIVAL SUPERFICIAL REMOVAL, IMPLANTABLE CONTRACEPTIVE CAPSULES REMOVAL, INTRAUTERINE DEVICE REMOVAL, SKIN TAGS, MULTIPLE FIBROCUTANEOUS TAGS, ANY AREA; UP TO & INCL 15 LESIONS REMOVAL, SUTURES UNDER ANESTHESIA (OTHER THAN LOCAL), OTHER SURGEON REPAIR, ENTEROCELE, VAGINAL APPROACH (SEP PROC) REPAIR, RECTOCELE (SEP PROC) RHO(D) IMMUNE GLOBULIN (RHIG), HUMAN, FULL-DOSE, IM USE ROUTINE OB CARE, ANTE/POSTPARTUM, CESAREAN DELIVERY AFTER FAILED VAG DELIV, PREV CESAREAN DELIV ROUTINE OBSTETRIC CARE W/ANTEPARTUM CARE, CESAREAN DELIVERY, & POSTPARTUM CARE ROUTINE OBSTETRIC CARE, ANTEPARTUM CARE, VAGINAL DELIVERY, & POSTPARTUM CARE ROUTINE OBSTETRIC CARE, VAGINAL DELIVERY, W/ANTEPARTUM, POSTPARTUM CARE, PREVIOUS C-SECTION SALINE INFUSION SONOHYSTEROGRAPHY, W/COLOR FLOW DOPPLER, WHEN PERFORMED SALPINGECTOMY, COMPLETE/PARTIAL, UNILAT/BILAT (SEP PROC) SALPINGO-OOPHORECTOMY, COMPLETE/PARTIAL, UNILAT/BILAT (SEP PROC) SCREENING MAMMOGRAPHY BILATERAL SICKLING, RBC, REDUCTION SIMPLE CYSTOMETROGRAM SIMPLE UROFLOWMETRY SKIN TEST; TUBERCULOSIS, INTRADERMAL SLING OPERATION, STRESS INCONTINENCE SMEAR, PRIMARY SOURCE W/INTERPRETATION; GRAM OR GIEMSA STAIN, BACTERIA/FUNGI/CELL TYPES SMEAR, PRIMARY SOURCE W/INTERPRETATION; WET MOUNT, FOR INFECTIOUS AGENTS SUBSEQUENT HOSP CARE 2+ KEY COMPONENTS: DETAILED INTERVL HX; DETAILED EXAM;MED DECISION HIGH SUBSEQUENT HOSP CARE 2+ KEY COMPONENTS:EXPAND PROB FOCUS INT HX;EXPAND PROB EXAM;MED DEC MOD SUBSEQUENT HOSP CARE 2+ KEY COMPONENTS:PROB FOCUS INT HX;PROB FOCUS EXAM;MED DEC STRTFWD/LOW SUBSEQUENT HOSPITAL CARE PER DAY E/M NORMAL NEWBORN SUBSEQUENT OBS CARE PER DAY LOW SEVERITY SUPPLIES PROVIDED BY PHYSICIAN OVER & ABOVE THOSE INCLUDED IN THE SERVICE SUPRACERVICAL ABDOMINAL HYSTERECTOMY, W/WO REMOVAL TUBE(S)/OVARY(S) SURGICAL TREATMENT, ECTOPIC PREGNANCY; TUBAL/OVARIAN W/SALPINGECTOMY/OOPHORECTOMY SUSCEPTIBILITY STUDIES, ANTIMICROBIAL AGENT; AGAR DILUTION METHOD, PER AGENT SYPHILIS TEST, NON-TREPONEMAL ANTIBODY; QUALITATIVE SYPHILIS TEST, NON-TREPONEMAL ANTIBODY; QUANTITATIVE TESTOSTERONE; FREE TESTOSTERONE; TOTAL TETANUS, DIPHTHERIA TOXOIDS AND ACELLULAR PERTUSIS VACCINE (TDAP), >7 YEARS, IM USE THERAPEUTIC PROPHYLACTIC/DX INJECTION SUBQ/IM THROMBOPLASTIN TIME, PARTIAL (PTT); PLASMA/WHOLE BLOOD THYROID HORMONE (T3/T4) UPTAKE/THYROID HORMONE BINDING RATIO (THBR) THYROID STIMULATING HORMONE (TSH) THYROXINE; FREE TISSUE EXAM BY KOH SLIDE OF SAMPLES FROM SKIN/HAIR/NAILS, FUNGI/ECTOPARASITE OVA/MITES TOBACCO USE CESSATION INTERMEDIATE 3-10 MINUTES TOTAL ABDOMINAL HYSTERECTOMY W/WO REMOVAL TUBE(S)/OVARY(S) TOTAL ABDOMINAL HYSTERECTOMY W/WO REMOVAL TUBE(S)/OVARY(S); W/COLPO-URETHROCYSTOPEXY TOTAL ABDOMINAL HYSTERECTOMY, W/PARTIAL VAGINECT, W/PELVIC NODE SAMPLE, W/WO REM TUBES/OVARIES TRANSFUSION, BLOOD/BLOOD COMPONENTS TREATMENT, INCOMPLETE ABORTION, ANY TRIMESTER, COMPLETED SURGICALLY TREATMENT, MISSED ABORTION, COMPLETED SURGICALLY; 1ST TRIMESTER TREATMENT, SUPERFICIAL WOUND DEHISCENCE; W/PACKING TRIIODOTHYRONINE T3; FREE ULTRASOUND FETAL NUCHAL TRANSLUCENCY 1ST GESTATION ULTRASOUND, ABDOMINAL, B-SCAN &/OR REAL TIME W/IMAGE DOCUMENTATION; LIMITED ULTRASOUND, ABDOMINAL, REAL TIME W/IMAGE DOCUMENTATION; COMPLETE ULTRASOUND, BREAST(S), REAL TIME W/IMAGE DOCUMENTATION ULTRASOUND, RETROPERITONEUM, REAL TIME; COMPLETE UNLISTED CYTOPATHOLOGY PROC UNLISTED EVALUATION & MANAGEMENT SERVICE UNLISTED PROC, BREAST UNLISTED PROC, FEMALE GENITAL SYSTEM (NONOBSTETRICAL) UNLISTED PROC, HYSTEROSCOPY, UTERUS UNLISTED PROC, LAPAROSCOPY, OVIDUCT/OVARY UNLISTED PROC, LAPAROSCOPY, UTERUS UNLISTED PROC, MATERNITY CARE & DELIVERY UNLISTED ULTRASOUND PROCEDURE URIC ACID; BLOOD URINALYSIS, DIP STICK/TABLET REAGENT; AUTOMATED W/MICROSCOPY URINALYSIS, DIP STICK/TABLET REAGENT; AUTOMATED, W/O MICROSCOPY URINALYSIS, DIP STICK/TABLET REAGENT; NON-AUTOMATED W/MICROSCOPY URINALYSIS, DIP STICK/TABLET REAGENT; NON-AUTOMATED, W/O MICROSCOPY URINALYSIS; BACTERIURIA SCREEN, EXCEPT BY CULTURE/DIPSTICK URINALYSIS; MICROSCOPIC ONLY URINALYSIS; QUALITATIVE/SEMIQUANTITATIVE, EXCEPT IMMUNOASSAYS URINE PREGNANCY TEST, VISUAL COLOR COMPARISON METHODS US BONE DENSITY MEASUREMENT & INTERPRETATION, PERIPHERAL SITE(S), ANY METHOD US GUIDANCE, AMNIOCENTESIS, IMAGING S&I US STUDY FOLLOW-UP (SPECIFY) US, PREG UTER, REAL TIME W/IMAGE DOC, FETAL & MATERNAL, + DETAIL FETAL EXAM, TRANSABD; EA ADD'L GEST US, PREG UTER, REAL TIME W/IMAGE DOC, FETL & MATRNL, + DETL FETL EXM, TRANSABD; SINGL/1ST ADD'L GEST US, PREG UTER, REAL TIME W/IMAGE DOCUMENT EA ADD'L GEST US, PREG UTER, REAL TIME W/IMAGE DOCUMENT, FETAL & MATERNAL, 1ST TRIMEST, TRANSABDOM; EA ADD'L GEST US, PREG UTER, REAL TIME W/IMAGE DOCUMENT, FETAL & MATERNAL, 1ST TRIMEST, TRANSABDOM; SINGL/1ST GEST US, PREG UTER, RLTIME W/IMAGE DOCUMENT, FETAL & MATERNL, 1ST TRIMST, TRANSABDM; SINGL/1ST ADD'L GEST US, PREGNANT UTERUS, REAL TIME W/IMAGE DOCUMENT, FOLLOW-UP, TRANSABD APPROACH, PER FETUS US, PREGNANT UTERUS, REAL TIME W/IMAGE DOCUMENT, LIMITED, 1/> FETUSES US, PREGNANT UTERUS, REAL TIME W/IMAGE DOCUMENT, TRANSVAGINAL VAGINAL DELIVERY ONLY (W/WO EPISIOTOMY &/OR FORCEPS) VAGINAL DELIVERY ONLY (W/WO EPISIOTOMY &/OR FORCEPS); W/POSTPARTUM CARE VAGINAL DELIVERY ONLY, PREVIOUS CESAREAN DELIVERY VAGINAL DELIVERY ONLY, PREVIOUS CESAREAN DELIVERY; W/POSTPARTUM CARE VAGINAL HYSTERECTOMY, UTERUS >250 GMS; VAGINAL HYSTERECTOMY, UTERUS >250 GMS; W/REMOVAL, TUBE(S) &/OR OVARY(S) VAGINAL HYSTERECTOMY, UTERUS 250 GMS/< VAGINAL HYSTERECTOMY, UTERUS 250 GMS/<; W/REMOVAL, TUBE(S) & OVARY(S) VAGINAL HYSTERECTOMY, UTERUS 250 GMS/<; W/REMOVAL, TUBE(S) & OVARY(S), W/REPAIR OF ENTEROCELE VAGINAL HYSTERECTOMY, UTERUS 250 GMS/<; W/REPAIR OF ENTEROCELE VAGINAL HYSTERECTOMY, W/TOTAL/PARTIAL VAGINECTOMY VAGINAL HYSTERECTOMY; W/TOTAL/PARTIAL VAGINECTOMY; W/REPAIR, ENTEROCELE VARICELLA VIRUS VACCINE, LIVE, SUBQ USE VENIPUNCTURE, AGE 3/>, REQ PHYSICIAN SKILL, (SEP PROC), DX/TX (EXCEPT ROUTINE) VITAMIN D; 25 HYDROXY, INCL FRACTION(S) IF PERFORMED VOIDING PRESSURE STUDIES; INTRA-ABDOMINAL VULVECTOMY SIMPLE; PARTIAL

CPT is a registered trademark of the American Medical Association